Suppr超能文献

吸入沙丁胺醇与沙丁胺醇和二丙酸倍氯米松联合用药治疗中度严重哮喘的比较

A comparison of inhaled salbutamol with a combination of salbutamol and beclomethasone dipropionate in moderately severe asthma.

作者信息

Chhabra S K

机构信息

Department of Cardiorespiratory Physiology, Vallabhabhi Patel Chest Institute, Delhi.

出版信息

Indian J Chest Dis Allied Sci. 1994 Jul-Sep;36(3):119-24.

PMID:7737699
Abstract

Fifteen adults with moderately severe asthma underwent two sequential treatments, first with inhaled salbutamol, 200 micrograms q.i.d. for 2 weeks followed by a combination of salbutamol 200 micrograms and beclomethasone dipropionate (BDP) 100 micrograms q.i.d. for the next 2 weeks. The response was evaluated by symptoms and additional drugs scores during the two treatments and spirometry before and after each treatment. The second phase of treatment resulted in a greater symptomatic improvement and a reduced need for additional drugs. A clinically significant improvement was observed in lung function after the combination treatment. However, as the comparison was limited to only 2 weeks, this duration of treatment was not adequate to correct the spirometric abnormalities. It was concluded that a combination of salbutamol and BDP was superior to salbutamol alone. Treatment with only bronchodilators results in a poor control of asthma and therefore, these should always be combined with inhaled steroids.

摘要

15名患有中度严重哮喘的成年人接受了两个连续疗程的治疗,首先吸入沙丁胺醇,每次200微克,每日4次,持续2周,随后在接下来的2周内,吸入沙丁胺醇200微克与二丙酸倍氯米松(BDP)100微克的组合,每日4次。通过两个疗程中的症状和额外药物评分以及每个疗程前后的肺功能测定来评估反应。第二阶段的治疗带来了更显著的症状改善,且对额外药物的需求减少。联合治疗后肺功能有临床显著改善。然而,由于比较仅局限于2周,这个治疗时长不足以纠正肺功能测定的异常。得出的结论是,沙丁胺醇与BDP的组合优于单独使用沙丁胺醇。仅使用支气管扩张剂治疗哮喘控制不佳,因此,这些药物应始终与吸入性类固醇联合使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验